<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31131404</article-id>
<article-id pub-id-type="pmc">6736100</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddz115</article-id>
<article-id pub-id-type="publisher-id">ddz115</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>General Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Learning impairments and molecular changes in the brain caused by <roman toggle="no">β</roman>-catenin loss</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wickham</surname>
<given-names>Robert J</given-names>
</name>
<!--<email>robert.wickham@tufts.edu</email>-->
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alexander</surname>
<given-names>Jonathan M</given-names>
</name>
<!--<email>skarut@gmail.com</email>-->
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eden</surname>
<given-names>Lillian W</given-names>
</name>
<!--<email>lillian.w.eden@gmail.com</email>-->
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Valencia-Yang</surname>
<given-names>Mabel</given-names>
</name>
<!--<email>mvalenciayang@gmail.com</email>-->
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Llamas</surname>
<given-names>Josué</given-names>
</name>
<!--<email>Josue.Llamas_Rodriguez@tufts.edu</email>-->
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aubrey</surname>
<given-names>John R</given-names>
</name>
<!--<email>john.aubrey@tufts.edu</email>-->
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jacob</surname>
<given-names>Michele H</given-names>
</name>
<!--<email>michele.jacob@tufts.edu</email>-->
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
</contrib-group>
<aff id="aff1">Department of Neuroscience, Sackler Biomedical Graduate School, Tufts University School of Medicine, Boston, MA 02111, USA</aff>
<author-notes>
<corresp id="cor1">To whom correspondence should be addressed at: Department of Neuroscience, Sackler Biomedical Graduate School, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA. Tel: 617-636-2429; Fax: 617-636-2413; Email: <email>Michele.Jacob@Tufts.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-05-20" pub-type="epub">
<day>20</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>28</volume>
<issue>17</issue>
<fpage>2965</fpage>
<lpage>2975</lpage>
<history>
<date date-type="received">
<day>7</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>5</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="ddz115.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Intellectual disability (ID), defined as IQ&lt;70, occurs in 2.5% of individuals. Elucidating the underlying molecular mechanisms is essential for developing therapeutic strategies. Several of the identified genes that link to ID in humans are predicted to cause malfunction of <roman toggle="no">β</roman>-catenin pathways, including mutations in <italic>CTNNB1</italic> (<roman toggle="no">β</roman>-catenin) itself. To identify pathological changes caused by <roman toggle="no">β</roman>-catenin loss in the brain, we have generated a new <roman toggle="no">β</roman>-catenin conditional knockout mouse (<roman toggle="no">β</roman>-cat cKO) with targeted depletion of <roman toggle="no">β</roman>-catenin in forebrain neurons during the period of major synaptogenesis, a critical window for brain development and function. Compared with control littermates, <roman toggle="no">β</roman>-cat cKO mice display severe cognitive impairments. We tested for changes in two <roman toggle="no">β</roman>-catenin pathways essential for normal brain function, cadherin-based synaptic adhesion complexes and canonical Wnt (Wingless-related integration site) signal transduction. Relative to control littermates, <roman toggle="no">β</roman>-cat cKOs exhibit reduced levels of key synaptic adhesion and scaffold binding partners of <roman toggle="no">β</roman>-catenin, including N-cadherin, <roman toggle="no">α</roman>-N-catenin, p120ctn and S-SCAM/Magi2. Unexpectedly, the expression levels of several canonical Wnt target genes were not altered in <roman toggle="no">β</roman>-cat cKOs. This lack of change led us to find that <roman toggle="no">β</roman>-catenin loss leads to upregulation of <roman toggle="no">γ</roman>-catenin (plakoglobin), a partial functional homolog, whose neural-specific role is poorly defined. We show that <roman toggle="no">γ</roman>-catenin interacts with several <roman toggle="no">β</roman>-catenin binding partners in neurons but is not able to fully substitute for <roman toggle="no">β</roman>-catenin loss, likely due to differences in the N-and C-termini between the catenins. Our findings identify severe learning impairments, upregulation of <roman toggle="no">γ</roman>-catenin and reductions in synaptic adhesion and scaffold proteins as major consequences of <roman toggle="no">β</roman>-catenin loss.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Neurological Disorders and Stroke</named-content>
<named-content content-type="funder-identifier">10.13039/100000065</named-content>
</funding-source>
<award-id>P30 NS047243</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of General Medical Sciences</named-content>
<named-content content-type="funder-identifier">10.13039/100000057</named-content>
</funding-source>
<award-id>K12GM074869</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Mental Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000025</named-content>
</funding-source>
<award-id>1R01MH106623</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="11"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>